# The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.

> **NCT01181934** · EARLY_PHASE1 · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 32 (actual)

## Conditions studied

- Schizophrenia
- Cognition Disorders

## Interventions

- **OTHER:** A643 (nicotine)
- **DRUG:** placebo
- **OTHER:** A643 (nicotine)

## Key facts

- **NCT ID:** NCT01181934
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** —
- **Final completion:** 2011-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181934, "The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01181934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*